Repligen Corporation RGEN
NASDAQ · United States · Health Technology
$181.32-10.91 (-5.68%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-28 | 0.54 | 0.45 | +20.8% | $204.13M | +1.3% | +7.8%$131.06→$141.23 |
| Q1 2026 | 2026-05-05 | 0.48 | 0.38 | +26.3% | — | — | +6.4%$118.21→$125.76 |
| Q4 2025 | 2026-02-24 | 0.49 | 0.44 | +11.4% | — | — | -2.4%$135.40→$132.14 |
| Q3 2025 | 2025-10-28 | 0.46 | 0.42 | +9.5% | — | — | -7.8%$161.10→$148.48 |
| Q2 2025 | 2025-07-29 | 0.37 | 0.39 | -5.1% | — | — | — |
| Q1 2025 | 2025-04-29 | 0.39 | 0.35 | +11.4% | — | — | — |
| Q4 2024 | 2025-02-20 | 0.44 | 0.41 | +7.3% | — | — | — |
| Q3 2024 | 2024-11-12 | 0.43 | 0.33 | +30.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.